Neuland Laboratories receives US FDA approval

Neuland Laboratories on Thursday informed the exchanges that the United States Food and Drug Administration inspected one of its manufacturing facilities (unit 2) at Pashmylaram, Patancheru, Sangareddy district, Telangana, on November 26-28. The inspection was completed successfully with no observations under Form 483, the company said. Shares of Neuland Laboratories jumped 5.65 per cent at ₹517.20 on the BSE.